Skip to main content
The Lamy Co., Ltd. logo

The Lamy Co., Ltd. — Investor Relations & Filings

Ticker · 032860 ISIN · KR7032860009 KO Manufacturing
Open in API
Filings indexed 584 across all filing types
Latest filing 2023-09-07 Major Shareholding Noti…
Country KR South Korea
Listing KO 032860

About The Lamy Co., Ltd.

https://www.lamy.com

The Lamy Co., Ltd. is a German manufacturer of high-quality designer writing instruments, renowned for its timeless modern aesthetic and functionality. Guided by the Bauhaus principle of 'form follows function,' the company's distinct design language was established with the iconic LAMY 2000 model. Its product portfolio includes traditional writing tools, such as the globally successful LAMY safari pen, and has expanded to include digital writing instruments like styluses compatible with various tablets and devices. The company has maintained its production in Heidelberg, ensuring high quality standards across its entire value chain. The brand is distributed globally in over 80 countries through numerous points of sale, including mono-brand stores.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details a change in shareholding (specifically a 10% or greater stake acquisition via third-party allocation) by a major shareholder, Omnisystem Co., Ltd., in the company HumanN. This type of filing is a standard regulatory disclosure for major shareholding notifications in the Korean market.
2023-09-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed in South Korea. This type of filing is a mandatory disclosure when a major shareholder or executive changes their stake in a company. In the provided taxonomy, this falls under 'Major Shareholding Notification' (MRQ) as it details a significant change in share ownership (10% or more shareholder) resulting from a third-party allocated capital increase.
2023-09-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea (often referred to as a 5% report). It details the acquisition of shares by Biosmart and Omni System in HumanN, including the purpose of the holding (management influence), the number of shares, and the source of funds. This falls under the category of Major Shareholding Notification.
2023-09-07 Korean
전환가액의조정(제11회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (11th series) issued by the company 'HumanN'. It details the specific changes to the conversion price and the number of convertible shares due to a capital increase (rights offering). This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2023-09-01 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a third-party capital increase (share issuance) by the company HumanN. It details the number of shares issued, the total amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2023-08-31 Korean
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) system regarding a change in the largest shareholder (최대주주변경) of the company 'HumanN'. It details the change in ownership, the reason (third-party capital increase), and the new controlling entity. While it mentions board appointments, the primary purpose is the disclosure of a change in control/shareholding structure, which falls under the category of general regulatory filings (RNS) as it is a standard corporate disclosure form.
2023-08-31 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.